Clinical management of continuous-flow left ventricular assist devices in advanced heart failure

Slaughter, Mark S.; Pagani, Francis D.; Rogers, Joseph G.; Miller, Leslie W.; Sun, Benjamin; Russell, Stuart D.; Starling, Randall C.; Chen, Leway; Boyle, Andrew; Chillcott, Suzanne; Adamson, Robert; Blood, Margaret S.; Camacho, M.; Idrissi, Katharine; Petty, Michael; Sobieski, Michael A.; Wright, Susan; Myers, Timothy J.; Farrar, David J.

doi:10.1016/j.healun.2010.01.011

Cited by 796 publications

(660 citation statements)

References 102 publications

(100 reference statements)

Supporting

Mentioning

632

Contrasting

Unclassified

Order By: Relevance

“…Initiation of warfarin and aspirin without IV UFH has become the standard for HeartMate II LVADs, the most frequently used device in the USA [1]. This study also suggested that the rate of thromboembolic events was extremely low with an INR target of 2.5-3.5; therefore, a lower target INR of 1.5-2.5 was determined to be sufficient to prevent thrombotic events with less bleeding complications [5,6].…”

Section: Anticoagulation Management Of Left Ventricular Assist Devicesmentioning

confidence: 95%

Anticoagulation management of left ventricular assist devices

Connors

2014

American J Hematol

View full text Add to dashboard Cite

Section: Anticoagulation Management Of Left Ventricular Assist Devicesmentioning

confidence: 95%

Anticoagulation management of left ventricular assist devices

Connors

2014

American J Hematol

View full text Add to dashboard Cite

“…All LVADs fall into one of two physiologic categories based on how blood is circulated through the device: pulsatile or non-pulsatile. Non-pulsatile, or continuous flow, LVADs are smaller in size, operate silently, and have greater durability when compared to pulsatile flow LVADs 43 .…”

Section: Ventricular Assist Devicementioning

confidence: 99%

Coexisting Cardiac and Hematologic Disorders

Goldhammer

Kohl

2016

Anesthesiology Clinics

View full text Add to dashboard Cite

“…For a detailed and technical review on device parameters, function, and troubleshooting, the clinician is referred to the HeartMate II instructions for use published by Thoratec and a recently published user's guide from the HeartMate II Clinical Investigators. 8 …”

Section: Lvad-related Complicationsmentioning

confidence: 99%

Implantable Mechanical Circulatory Support: Demystifying Patients With Ventricular Assist Devices and Artificial Hearts

Shah¹,

Tang²,

Cooke³

et al. 2011

Clinical Cardiology

View full text Add to dashboard Cite

Engineering advancements have expanded the role for mechanical circulatory support devices in the patient with heart failure. More patients with mechanical circulatory support are being discharged from the implanting institution and will be seen by clinicians outside the immediate surgical or heart-failure team. This review provides a practical understanding of device design and physiology, general troubleshooting, and limitations and complications for implantable left ventricular assist devices (pulsatile-flow and continuous-flow pumps) and the total artificial heart.

show abstract

Clinical management of continuous-flow left ventricular assist devices in advanced heart failure

Cited by 796 publications

References 102 publications

Anticoagulation management of left ventricular assist devices

Anticoagulation management of left ventricular assist devices

Coexisting Cardiac and Hematologic Disorders

Implantable Mechanical Circulatory Support: Demystifying Patients With Ventricular Assist Devices and Artificial Hearts

Contact Info

Product

Resources

About